General American Investors Company

Broadcom is a global designer, developer and supplier of analog and digital semiconductor connectivity solutions. Its portfolio includes more than 6,500 devices spanning analog and digital technologies, designed for wireless communications, wired infrastructure, industrial and automotive electronics, and consumer and computing peripherals. The company's products support applications such as cellular phones, data networking and telecommunications equipment, enterprise storage and servers, renewable energy and smart grids, factory automation, displays, optical mice and printers. The range covers simple discrete components to complex subsystems that incorporate firmware to interface between digital systems, and may include mechanical hardware that interfaces with optoelectronic or capacitive sensors.

Kindred Biosciences is a veterinary biotechnology company based in San Francisco, California, dedicated to developing innovative therapies for dogs, cats, and horses. Founded in 2012, the company specializes in creating canine, feline, and equine antibodies aimed at treating various diseases in companion animals. Kindred Biosciences focuses on identifying compounds and targets that have previously demonstrated safety and efficacy in humans, leveraging these validated elements to develop therapeutics specifically for pets. The company maintains a diverse pipeline of novel biologics across multiple therapeutic classes, backed by robust biologics manufacturing capabilities and an extensive intellectual property portfolio. Through its efforts, Kindred Biosciences strives to provide pets with access to the same safe and effective medicines that are available to humans, reflecting its commitment to improving and saving the lives of animals.